Atria Wealth Solutions’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Atria Wealth Solutions's PFE Position: Q2 2025 in Review
Atria Wealth Solutions reduced its Pfizer (PFE) stake by 66% in Q2 2025, selling an estimated $8.91M and leaving 195,671 shares worth $4.78M. The position accounts for 0.11% of the portfolio, ranked #218.
Atria Wealth Solutions first reported a position in PFE in Q1 2022 and has held it in 14 quarters since. The position peaked at $26.2M in Q4 2022. 2,813 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Atria Wealth Solutions held 195,671 shares of Pfizer worth $4.78M as of Q2 2025.
- Atria Wealth Solutions sold 381,972 Pfizer shares in Q2 2025, an estimated $8.91M.
- Pfizer made up 0.11% of Atria Wealth Solutions's portfolio in Q2 2025, its #218 holding.
- Atria Wealth Solutions first reported a position in Pfizer in Q1 2022 and has held it in 14 quarters since.
- Atria Wealth Solutions's Pfizer position peaked at $26.2M in Q4 2022.
- 2,813 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.